Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor

Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor

US Patent 11679082 · Granted Jun 20, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2024
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2024
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2024
Cross-linked polymer modified nanoparticles2022
Cross-linked polymer modified nanoparticles2022
Immunotherapeutic constructs and methods of their use2022
Immunotherapeutic constructs and methods of their use2022
Immunotherapeutic constructs and methods of their use2022
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2022
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2022
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2022
Cross-linked polymer modified nanoparticles2021